Aripiprazole Tablets recalled over manufacturing violations
- Recall date
- January 10, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Hetero Labs, Ltd. - Unit III recalls Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway,…
- Recall number
- D-0594-2018
- FDA classification
- Class II
- Brand / firm
- Hetero Labs, Ltd. - Unit III
- Sold / distributed
- NJ Only
Why it was recalled
CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30
Get recall alerts
Free email alert whenever Hetero Labs, Ltd. - Unit III has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hetero Labs, Ltd. - Unit III